Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine
From Wikipedia, the free encyclopedia
Jump to navigation
Jump to search
Vaccine candidate against COVID-19
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | Protein subunit |
Clinical data | |
Routes of administration | Intramuscular |
Part of a series on the |
COVID-19 pandemic |
---|
|
|
|
|
COVID-19 portal |
Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine is a COVID-19 vaccine candidate developed by Zhongyianke Biotech, Liaoning Maokangyuan Biotech, and Academy of Military Medical Sciences.[1][2]
References[edit]
- ^ "Phase I Trial of a Recombinant COVID-19 Vaccine (CHO Cell)". clinicaltrials.gov. United States National Library of Medicine. Retrieved 13 April 2021.
- ^ "Immunogenicity and Safety of Recombinant COVID-19 Vaccine (CHO Cells)". clinicaltrials.gov. United States National Library of Medicine. Retrieved 13 April 2021.
Scholia has a profile for Zhongyianke Biotech–Liaoning Maokangyuan Biotech COVID-19 vaccine (Q106652103). |
Development | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Classes | |||||||||||
Administration | |||||||||||
Vaccines |
| ||||||||||
Inventors/researchers | |||||||||||
Controversy | |||||||||||
Related | |||||||||||
|
This article about the COVID-19 pandemic is a stub. You can help Wikipedia by expanding it. |
This article about vaccines or vaccination is a stub. You can help Wikipedia by expanding it. |
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Use dmy dates from April 2021
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a vaccine
- All stub articles